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Out in the field
Analysis of squamous cell carcinomas led to the concept of field 
cancerization, which refers to histologically abnormal epithe-
lium adjacent to tumors and the prevalence of multiple local 
secondary tumors and synchronous distant tumors. Molecular 
alterations of the mesenchyme in this situation have not been 
studied extensively. Hu and colleagues recently demonstrated 
that loss of mesenchymal Notch/CSL signaling in mice results 
in a phenotype reminiscent of field cancerization with multifo-
cal tumors, expanded alterations of the surrounding epithelium, 
and atrophic changes of the underlying stroma. In addition, CSL 
deletion resulted in increased expression of mitogenic and/or 
proinflammatory genes in fibroblasts and keratinocytes. Notably, 
treatment of these CSL mutant mice with an anti-inflammatory 
agent (COX-2 inhibitor) delayed the formation of focal lesions 
and tumors, suggesting that such treatment may be useful to pre-
vent or retard secondary tumor development in patients. These 
investigators found that UVA exposure exerts a rapid negative 
effect on the expression of Notch receptors in the dermis of skin 
explants and in dermal fibroblasts. This finding was not surprising 
given that cutaneous field cancerization typically occurs on sun-
exposed areas. (Cell 149:1207–20, 2012) Selected by S. Yuspa
Unconventional activity
The most common genetic lesions associated with human can-
cers are p53 mutations; thus, understanding the mechanisms 
underlying the tumor suppressor activity of this transcription 
factor is at the forefront of the molecular oncology field. Li and 
colleagues fortuitously found that acetylation-defective p53 
mutant mice were deficient for p53-mediated cell cycle arrest, 
apoptosis, and senescence. Thus, these mice provided an excel-
lent instrument to determine that the combined loss of these 
p53 functions is not sufficient to abrogate the p53 tumor sup-
pressor activity because the mice failed to develop early-onset 
spontaneous tumors similar to p53 null animals. Additionally, 
the p53 acetylation mutant appeared to retain tumor suppressor 
activity via its ability to regulate energy metabolism and reac-
tive oxygen species levels. These groundbreaking results clearly 
show that the canonical functions of p53 are not essential for 
tumor suppression and suggest that other unconventional p53 
activities are critical for tumor suppression. (Cell 149:1269–83, 
2012) Selected by S. Yuspa
Ramp down the damage
Aberrant IgA–antigen complex deposition is characteristic of 
many inflammatory diseases, including celiac disease, IgA 
pemphigus, dermatitis herpetiformis, and linear IgA bullous dis-
ease (LABD). In addition, cross-linking of the granulocyte IgA 
FcR by IgA amplifies granulocyte recruitment to IgA deposits 
to defend against pathogens. Recently, van der Steen and col-
leagues utilized the IgA-dependent skin-blistering disease LABD 
as a model system to demonstrate that abnormal deposition of 
IgA–antigen complexes in tissues induces sustained granulo-
cyte recruitment via cross-linking of FcαR1. More importantly, 
blockade of this interaction between IgA and FcαR1 abolished 
the inflammatory loop of granulocyte infiltration, and this 
alteration effectively reduced tissue damage. Thus, this inter-
action offers a new target for the development of therapeutics 
for diseases associated with IgA–antigen complex deposition. 
(J Immunol 189:1594–601, 2012) Selected by J. Stanley
More needles in the haystack
Genome-wide association studies have revealed more than 20 
susceptibility loci for psoriasis, although the risk conferred by 
each of these loci is small and, to date, less than 20% of the dis-
ease variance has been explained. Following identification of 
rare, gain-of-function mutations in the NF-κB activator caspase 
recruitment domain member 14 (CARD14) in families affected 
by psoriasis and psoriatic arthritis, Jordan and colleagues iden-
tified and characterized 15 additional rare missense variants 
within this gene. Statistical analysis showed an excess of rare 
variants in the cohort of nearly 6,000 psoriasis cases as com-
pared with controls. Variants that led to NF-κB activation were 
considered putative pathogenic variants. In addition, transcrip-
tome profiling of variant CARD14 transfectants segregated the 
potentially pathogenic mutations from the likely neutral poly-
morphisms. These studies provide evidence that both rare and 
common CARD14 variants predispose individuals to psoriasis 
and possibly to psoriatic arthritis; they simultaneously illustrate 
the challenges inherent in searching for rare variants associated 
with common disease. (Am J Hum Genet 90:796–808, 2012) 
Selected by J. Uitto
Chaperone function in PPK
The familiar skin disease punctate palmoplantar keratoderma 
(PPKP) is characterized by epidermal hyperkeratosis of the palms 
and soles and is transmitted largely in an autosomal-dominant 
manner. Despite recent mapping refinements to a critical region 
on chromosome 15, the molecular basis of PPKP1 has not yet 
been elucidated. In an analysis of 14 affected and 24 unaffected 
individuals from three families, Giehl and colleagues identified 
two heterozygous nonsense mutations—c.370C>T (p.Arg124*) 
and c.481C>T (p.Arg1618)—in AAGAB, the gene encoding the 
α- and γ-adaptin-binding protein 34 that functions in membrane 
trafficking. Functional analysis of these mutations indicated low 
or undetectable expression of these alleles, supporting haplo-
insufficiency as a disease-causing mechanism. Furthermore, 
granular cytoplasmic staining of this protein was reduced in the 
skin of affected individuals. These studies uncovered the genetic 
basis for PPKP1 in these three families and highlighted a role of 
AAGAB in skin integrity. (Am J Hum Genet 91:754–9, 2012) 
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